Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma: Identification, Characterization and Clinical Implications
Head and neck squamous cell carcinoma (HNSCC) is the sixth most commonly diagnosed cancer worldwide. Despite advances in the treatment management, locally advanced disease has a poor prognosis, with a 5-year survival rate of approximately 50%. The growth of HNSCC is maintained by a population of can...
Main Authors: | Claudia Peitzsch, Jacqueline Nathansen, Sebastian I. Schniewind, Franziska Schwarz, Anna Dubrovska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/5/616 |
Similar Items
-
Taxanes in the Treatment of Head and Neck Squamous Cell Carcinoma
by: Ching-Yun Hsieh, et al.
Published: (2023-10-01) -
Head and neck malignant lymphoma and squamous cell carcinoma discernment, is DWI conclusive?
by: Dina Gameel Anis, et al.
Published: (2023-12-01) -
The Role of Inflammation-Associated Factors in Head and Neck Squamous Cell Carcinoma
by: Li K, et al.
Published: (2023-09-01) -
Sarcopenia as a Prognostic Marker in Elderly Head and Neck Squamous Cell Carcinoma Patients Undergoing (Chemo-)Radiation
by: Erik Haehl, et al.
Published: (2022-11-01) -
Antitumor Efficacy of EGFR-Targeted Recombinant Immunotoxin in Human Head and Neck Squamous Cell Carcinoma
by: Guiqin Xie, et al.
Published: (2022-03-01)